Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 12553
TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708789(1-(4-(3-(2- (difluoromethyl)pyridin-4-yl)-2- ethyl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708772(1-(4-(3-(1H-indol-5-yl)-1H- pyrrolo[2,3-b]pyridin-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708773(3-(1H-indol-5-yl)-5-(4-((4- methoxypiperidin-1- yl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708775(1-(4-(1H,1'H-[3,5'- bipyrrolo[2,3-b]pyridin]-5- yl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708776(1-(4-(3-(1H-indazol-6-yl)-1H- pyrrolo[2,3-b]pyridi...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708777(1-(4-(3-(1H-indazol-4-yl)-1H- pyrrolo[2,3-b]pyridi...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708778(1-(4-(3-(benzo[d]oxazol-5-yl)- 1H-pyrrolo[2,3-b]py...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708779(1-(4-(3-(2- methylbenzo[d]oxazol-5-yl)- 1H-pyrrolo...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708780(1-(4-(3-(7- fluorobenzo[d]oxazol-5-yl)-1H- pyrrolo...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708781(2-hydroxy-5-(5-(4-((3- hydroxypiperidin-1- yl)meth...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708784(1-(4-(2-chloro-3-(6- methoxypyridin-3-yl)-1H- pyrr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708785(1-(4-(2-ethyl-3-(3- fluorophenyl)-1H-pyrrolo[2,3- ...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708786(1-(4-(3-(6- (difluoromethyl)pyridin-3-yl)-2- ethyl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708787(1-(4-(2-ethyl-3-(6- methoxypyridin-3-yl)-1H- pyrro...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708788(1-(4-(2-ethyl-3-(2- fluoropyridin-4-yl)-1H- pyrrol...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708774(3-(1H-indol-5-yl)-5-(4-((3- methoxyazetidin-1- yl)...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708791(1-(4-(3-(3-fluorophenyl)-2- (methoxymethyl)-1H- py...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708793(1-(4-(3-(2-fluoropyridin-4-yl)-2- (methoxymethyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708794(1-(4-(3-(2- (difluoromethyl)pyridin-4-yl)-2- (meth...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708795(1-(4-(2-(ethoxymethyl)-3-(3- fluorophenyl)-1H-pyrr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708803(1-(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708804(1-(4-(3-(1H-indol-5-yl)-1H- pyrrolo[2,3-b]pyridin-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708806(1-(4-(3-(1H-indol-5-yl)-1H- pyrrolo[2,3-b]pyridin-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708807(3-(1H-indol-5-yl)-5-(4- (piperidin-1-ylmethyl)phen...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708808(1-(4-(3-(1,2,3,4- tetrahydroisoquinolin-6-yl)-1H- ...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708811(1-(4-(3-(4- (hydroxymethyl)phenyl)-1H- pyrrolo[2,3...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708812(1-(4-(3-(2-methyloxazolo[5,4- b]pyridin-6-yl)-1H-p...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708813(1-(4-(3-(4-(2-hydroxypropan-2- yl)phenyl)-1H-pyrro...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708814(1-(4-(3-(2-fluoropyridin-4-yl)-2- (furan-3-yl)-1H-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708818(1-(4-(2-(cyclopropylmethyl)-3- (3-fluorophenyl)-1H...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708744(1-(4-(3-(4-hydroxyphenyl)-1H- pyrrolo[2,3-b]pyridi...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708730(1-(4-(3-(m-tolyl)-1H- pyrrolo[2,3-b]pyridin-5- yl)...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708732(1-(4-(3-(3-fluorophenyl)-1H- pyrrolo[2,3-b]pyridin...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708737(1-(4-(3-(3- (difluoromethyl)phenyl)-1H- pyrrolo[2,...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708740(1-(4-(3-(3,5-difluorophenyl)- 1H-pyrrolo[2,3-b]pyr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708742(4-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708743(3-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708745(1-(4-(3-(4- ((dimethylamino)methyl)phenyl)- 1H-pyr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708746(5-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708751(1-(4-(3-(6- (difluoromethyl)pyridin-3-yl)- 1H-pyrr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708753(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3-b]...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708754(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3-b]...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708736(1-(4-(3-(3-chlorophenyl)-1H- pyrrolo[2,3-b]pyridin...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708790(1-(4-(3-(6-methoxypyridin-3- yl)-2-methyl-1H-pyrro...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708792(1-(4-(3-(6-fluoropyridin-3-yl)-2- (methoxymethyl)-...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708771(1-(4-(3-(6- (hydroxymethyl)pyridin-3-yl)- 1H-pyrro...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708796(1-(4-(2-(difluoromethyl)-3-(3- fluorophenyl)-1H-py...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708798(5-(4-((3- (methoxymethyl)piperidin-1- yl)methyl)ph...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708799(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3-b]...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandPNGBDBM708739(1-(4-(3-(3- (trifluoromethyl)phenyl)-1H- pyrrolo[2...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: